These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2936354)

  • 1. [Comparative study of the central nervous system effect of the beta receptor blockaders pindolol and bisoprolol].
    Görtelmeyer R; Klingmann I
    Arzneimittelforschung; 1985; 35(11):1707-10. PubMed ID: 2936354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.
    Wheeldon NM; MacDonald TM; Prasad N; Maclean D; Peebles L; McDevitt DG
    QJM; 1995 Aug; 88(8):565-70. PubMed ID: 7648243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The blood pressure lowering effect of bisoprolol, a beta 1-selective receptor blocker--a multicenter study in general practice conditions].
    Haustein KO
    Z Gesamte Inn Med; 1993 Oct; 48(10):476-9. PubMed ID: 8256466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
    Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
    Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
    Bueno J; Amiguet JA; Carasusan J; Cebollada J; Carretero J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S189-92. PubMed ID: 11527126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisoprolol pilot studies in myocardial infarction.
    de Muinck ED; Lie KI; von Mengden HJ; Reck R; Verkenne P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S196-200. PubMed ID: 11527129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bisoprolol and verapamil in hypertension: influence on left ventricular mass and function--a pilot study.
    Gosse P; Gressin V; Clerson P; Lemetayer P; Clémenty J
    Therapie; 1999; 54(2):217-22. PubMed ID: 10394257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo].
    Weigmann I; Terhaag B; Wierich W; Herrmann WM
    Arzneimittelforschung; 1998 Mar; 48(3):240-4. PubMed ID: 9553680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of intrinsic sympathomimetic activity of the beta blocker carteolol. II: Comparative studies of carteolol and pindolol in patients with bradycardia].
    Lohmöller G; Middeke M; Mrowka C; Pötzl C; Renner W; Zoller W
    Med Klin (Munich); 1989 Feb; 84(2):81-5. PubMed ID: 2651861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The antihypertensive effect of the new cardioselective prolonged-action beta-adrenoblocker bisoprolol compared with propranolol, metoprolol and placebo].
    Metelitsa VI; Duda SG; Gorbunov VM; Buchner-Moll D; Deev AD; Vygodin VA; Filatova NP; Chel'dieva EIa; Shastun RS; Simonov DV
    Eksp Klin Farmakol; 1995; 58(2):32-4. PubMed ID: 7773086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.
    Potempa KM; Fogg LF; Fish AF; Kravitz HM
    Heart Lung; 1993; 22(5):383-91. PubMed ID: 8226001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experiences with carteolol in patients with essential hypertension].
    Viehmann P
    Arzneimittelforschung; 1983; 33(2a):322-5. PubMed ID: 6340701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.